Weight-reducing Effect of Diguanides in Obese Non-diabetic Women
- 5 April 1969
- Vol. 2 (5648) , 13-15
- https://doi.org/10.1136/bmj.2.5648.13
Abstract
A double-blind trial was carried out to assess the weight-reducing effect of the diguanides in 90 women with refractory obesity and normal oral glucose tolerance. The daily dosage of phenformin and metformin was increased at weekly intervals up to 300 mg. and 3 g. respectively, and patients were maintained at this dose or on the maximum they could tolerate without anorexia or other gastrointestinal side-effects. Seventy-seven completed the 16-week period of study. There was a statistically significant difference between the mean weight change of the control and the treated groups, but no difference between those treated by phenformin or metformin. The weight-losing influence of the diguanides appeared to be no longer significant after the twelfth week of treatment.Keywords
This publication has 14 references indexed in Scilit:
- EFFECT OF DIET, SULPHONYLUREAS, AND PHENFORMIN ON PERIPHERAL GLUCOSE UPTAKE IN DIABETES AND OBESITYThe Lancet, 1968
- Glucose Metabolism in Normal and Obese Subjects: Effect of PhenforminDiabetes, 1968
- OBSERVATIONS ON THE MECHANISM OF INCREASED WEIGHT LOSS DURING METFORMIN ADMINISTRATION IN OBESITYActa Endocrinologica, 1968
- PHENFORMIN IN HUMAN OBESITYAnnals of the New York Academy of Sciences, 1968
- GLUCOSE KINETICS BEFORE AND AFTER PHENFORMIN IN THE HUMAN SUBJECT*Annals of the New York Academy of Sciences, 1968
- COMPARISON OF CHLORPROPAMIDE AND METFORMIN TREATMENT ON WEIGHT AND BLOOD-GLUCOSE RESPONSE OF UNCONTROLLED OBESE DIABETICSThe Lancet, 1968
- Fatal lactic acidosis after an overdose of phenformin.BMJ, 1967
- Treatment of refractory obesity with fenfluramine.BMJ, 1966
- Irreversible Lactic Acidosis Associated With Phenformin TherapyJAMA, 1963
- Diethylpropion in the Treatment of "Refractory" ObesityBMJ, 1961